ArtNr |
TRC-M203560-50g |
Hersteller |
Toronto Research Chemicals
|
CAS-Nr. |
71-58-9 |
Menge |
50 g |
Quantity options |
100 g
10 g
1 g
25 g
50 g
50 mg
|
Kategorie |
|
Typ |
Biochemicals |
Specific against |
other |
Purity |
98% |
InCHI |
1S/C24H34O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h13-14,18-20H,6-12H2,1-5H3/t14-,18+,19-,20-,22+,23-,24-/m0/s1 |
Smiles |
O=C1CC[C@@]2(C)C([C@@H](C)C[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@]3(CC[C@]4(OC(C)=O)C(C)=O)[H])=C1 |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
6alpha-Methyl-3,20-dioxopregn-4-en-17-yl acetate; Medroxyprogesterone acetate; Megestrol Acetate Imp. A (EP); Amen; Aragest; Aragest 5; Asconale; CBP 1011; Clinofem; Clinovir; Colirest; Curretab; Cycrin; DMPA; Depo-Clinovir; Depo-Prodasone; Depo-Provera; Depo-Ralovera; Depo-SubQ Provera 104; Depo-progestin; Depo-promone; Depomedroxyprogesterone acetate; Depot-medroxyprogesterone acetate; Farlutal; Farlutin; G-Farlutal; Gestapuran; Hematrol; Hysron; Indivina; Lutopolar; Lutoral; MAP; MAP (steroid); MPA; MPA Gyn 5; Med-Pro; Medroprogesterone acetate; Medroxyprogesterone 17-acetate; Meprate; Metigestrona; NSC 21171; NSC 26386; Nadigest; Nidaxin; Novo-Medrone; Oragest; Perlutex; Perlutex Leo; Prempack C; Prodasone; Progespon; Progestalfa; Progeston; Progevera; Provera; Proverone; Ralovera; Repromap; Repromix; Sirprogen; Sodelut G; U 8839; Veramix; Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)-; Pregn-4-ene-3,20-dione, 17-hydroxy-6alpha-methyl-, acetate (7CI,8CI); Progesterone, 17-hydroxy-6alpha-methyl-, acetate (6CI); (6alpha)-17-(Acetyloxy)-6-methylpregn-4-ene-3,20-dione; 17alpha-Acetoxy-6alpha-methylpregn-4-ene-3,20-dione; 17alpha-Acetoxy-6alpha-methylprogesterone; 17alpha-Hydroxy-6alpha-methyl-4-pregnene-3,20-dione 17-acetate; 17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate; 17alpha-Hydroxy-6alpha-methylprogesterone acetate; 6alpha-Methyl-17-acetoxyprogesterone; 6alpha-Methyl-17R-hydroxyprogesterone acetate; 6alpha-Methyl-17alpha-Hydroxy-4-pregnene-3,20-dione acetate; 6alpha-Methyl-17alpha-acetoxy-Delta4-pregnene-3,20-dione; 6alpha-Methyl-17alpha-acetoxypregn-4-ene-3,20-dione; 6alpha-Methyl-17alpha-hydroxyprogesterone acetate; Megestrol Acetate Impurity A |
Lieferbar |
|
Mol. Weight |
386, 52 |
Country of Origin |
Canada |
IUPAC |
[(6S, 8R, 9S, 10R, 13S, 14S, 17R)-17-acetyl-6, 10, 13-trimethyl-3-oxo-2, 6, 7, 8, 9, 11, 12, 14, 15, 16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate |
Storage Condition |
4 |
Shipping Condition |
RT |
Shipping Info |
Not a Dangerous good |
Hazardous Class |
Suspected of causing cancer |
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.